Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hazard Ratio01:12

Hazard Ratio

106
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
106
Hazard Rate01:11

Hazard Rate

96
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
96
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

166
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
166
Odds Ratio01:09

Odds Ratio

115
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
115
Relative Risk01:12

Relative Risk

129
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
129
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

114
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
114

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sample Size Recalculation in Adaptive Group Sequential Study Designs for Comparing Restricted Mean Survival Times.

Statistics in medicine·2026
Same author

Permutation Tests Based on the Copula-Graphic Estimator and Their Use for Survival Tree Construction.

Statistics in medicine·2026
Same author

Beyond Bonferroni: new multiple contrast tests for time-to-event data under non-proportional hazards.

Lifetime data analysis·2026
Same author

Early and Late Buzzards: Comparing Different Approaches for Quantile-Based Multiple Testing in Heavy-Tailed Wildlife Research Data.

Biometrical journal. Biometrische Zeitschrift·2025
Same author

Comparing Statistical and Machine Learning Methods for Time Series Forecasting in Data-Driven Logistics-A Simulation Study.

Entropy (Basel, Switzerland)·2025
Same author

Lingual artery thrombosis as a presentation of infective endocarditis in a pregnant patient: a case report.

European heart journal. Case reports·2025
Same journal

Ensuring Quality in Preclinical Research: The Importance of Being Human.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

Addressing Cluster-Level Treatment Effect Heterogeneity in Sample Size Determination for Hierarchical 2 × 2 Factorial Designs.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

A Multiple Imputation Approach to Distinguish Curative From Life-Prolonging Effects in the Presence of Missing Covariates.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

Tests for Categorical Data Beyond Pearson: A Distance Covariance and Energy Distance Approach.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

Nonparametric Estimation of the Patient-Weighted While-Alive Estimand.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

Two-Stage Multiple Test Procedures Controlling False Discovery Rate With Auxiliary Variable and Their Application to Set4 <math><semantics><mi>Δ</mi> <annotation>$\Delta$</annotation></semantics></math> Mutant Data.

Biometrical journal. Biometrische Zeitschrift·2026
See all related articles

Related Experiment Video

Updated: Jun 17, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K

Sample Size Calculation Under Nonproportional Hazards Using Average Hazard Ratios.

Ina Dormuth1, Markus Pauly1,2, Geraldine Rauch3,4

  • 1Department of Statistics, TU Dortmund University, Dortmund, Germany.

Biometrical Journal. Biometrische Zeitschrift
|August 12, 2024
PubMed
Summary
This summary is machine-generated.

The average hazard ratio (AHR) offers a powerful alternative to traditional hazard ratios for clinical trials with nonproportional hazards. Simulation-based sample size calculations for AHR tests enhance statistical power and improve sample efficiency.

Keywords:
effect measurehazard ratiolog‐rank testsample sizesimulation studysurvival analysistime‐to‐event data

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K

Related Experiment Videos

Last Updated: Jun 17, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Survival Analysis

Background:

  • Time-to-event endpoints are crucial in clinical trials.
  • Hazard ratios (HRs) are commonly used but assume proportional hazards (PHs).
  • Nonproportional hazards (N-PHs) limit the interpretability and applicability of standard HRs.

Purpose of the Study:

  • To introduce and facilitate the practical application of the average hazard ratio (AHR) as an effect measure.
  • To develop and assess methods for sample size calculation for AHR tests.
  • To address the limitations of HRs in scenarios with nonproportional hazards.

Main Methods:

  • Developed sample size calculation approaches for AHR tests.
  • Conducted extensive simulation studies to evaluate sample size calculation reliability.
  • Simulations covered diverse survival and censoring distributions, including both proportional and nonproportional hazards.

Main Results:

  • The average hazard ratio (AHR) effectively handles time-varying effects without requiring proportional hazards.
  • Simulation-based sample size calculation approaches are reliable for designing clinical trials with N-PHs.
  • Utilizing AHR can lead to increased statistical power and more efficient sample sizes compared to traditional methods.

Conclusions:

  • The average hazard ratio (AHR) is a valuable tool for analyzing time-to-event data, particularly when hazards are nonproportional.
  • Simulation-based sample size calculations enhance the design of clinical trials employing AHR.
  • AHR facilitates more powerful and sample-efficient detection of group differences in time-to-event outcomes.